DIAGNOVITAL INFLUENZA A/B SARS-CoV-2 Multiplex Kit is a Real Time PCR-based diagnostic test for the in vitro qualitative detection and discrimination of SARS-CoV-2, Influenza A virus, Influenza B virus RNA in respiratory specimens.

SARS-CoV-2 is considered a novel human coronavirus which cause seasonal acute respiratory illness. The influenza virus A and B are the most common types of circulating influenza virus, and type A is responsible for the majority of influenza epidemics. The SARS-CoV-2 and Influenza A/B viruses may rise very similar symptoms.


  • Detection of INFLUENZA A/B and SARS CoV 2
  • Sample Type: Nasopharyngeal & oropharyngeal swab and bronchoalveolar lavage
  • Target genes:
    • SARS CoV 2 Nucleocapside (N) gene
    • Influenza A Matrix 1 (M1) gene
    • Influenza B Nonstructural protein 2 (NS2) gene
    • Human extraction control RNaseP gene
  • 3 Different Channels: FAM™ for the INFA/B, TEXAS RED for the SARS CoV 2 and the RNAseP (HEC) is detected in the HEX/VIC channel
  • Components: PCR master mix, positive and negative controls.
  • Validated Devices:
    • BIO-RAD CFX96
    • Rotorgene 3000/6000 Real-Time PCR Detection System
    • Applied Biosystems 7500
    • QuantStudio 5 Real-Time PCR Detection
    • Himedia Insta Q96 Real Time PCR Detection System
  • It is compatible with any thermal cyclers that have FAM, HEX/VIC and TEXAS RED Channel